cell4pharma, have developed 3 cell lines to empower researchers to accurately identify and eliminate the nephro-toxic compounds during preclinical research and increase your drug development success rate in clinical stages.
tebu-bio uses cookies on this website to ensure you the best possible
browsing experience each time you visit us. These small cookie files
are stored and used by your browser to personalise your visit. By
continuing your visit to the tebu-bio website without changing your
settings, you agree to use of these cookies. For more information,
please read our Privacy
Policy.